Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon L McClellan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to RadiationFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Research Square|September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to RadiationFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Research Square|September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Pageof 2